Friday, October 16, 2020 1:14:56 AM
His job is to lie to investors and pumping the stock so that Mark Miller can use LEAS to make money through an insider enrichment scheme.
The scam is simple.
Mark Miller, Lance Lance Quartieri and Dennie Bolbat hijacked the LEAS shell back in April 2019.
https://www.scribd.com/document/457798353/What-the-Heck-is-Going-on-With-LEAS-and-BBDA
After failing to put a fake back dated $25,000 debt Note on the books in the name of their buddy Gary Kouletas (PAG Group LLC), instead they issued a $4,594 Note to Mark Miller (hiding behind a nominee named Huang Tran) which converts at $.00001/share.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158895651
That's 459,400,000 shares.
While the CEO has been lying to everybody on Twitter and in press release, Miller's been converting and dumping in chunks.
60,000,000 at the start of July
70,000,000 at the end of July
70,000,000 in early/mid August
80,000,000 at the end of September
90,000,000 in early/mid October
Each new round of dilution has come with a new pump to support the dumping.
At an average selling price of $.003/share, Miller will make $1,378,000.
pretty crazy huh?
There is still at least one more big round of 90,000,000 shares to go
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158932391
Then after Miller is done, Bolbat will start converting his $50,000 Note which he gave himself for selling the LEAS shell to Jason Tucker.
So in other words, Tucker didn't pay a penny. Instead Bolbat got a $50,000 Note and it will be paid by the shareholders because Bolbat will be able to convert that $50,000 Note into 500,000,000 shares, which he'll sell into the market.
I've been posting about it for a long time now, but people keep buying into the pumps and losing money anyways.
That's how penny stocks works. They are all scams. And some people get fooled into thinking otherwise - those are the ones that lose the most money.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM